Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Liang, Jian Wei ^a   Shi, Zhi Zhou ^b   Shen, Tian Yun ^b   Che, Xu ^a   Wang, Zheng ^a   Shi, Su Sheng ^a   Xu, Xin ^a   Cai, Yan ^a   Zhao, Ping ^a   Wang, Cheng Feng ^a   Zhou, Zhi Xiang ^a   Wang, Ming Rong ^a  

^a CANCER HOSPITAL   (China)

^b KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2C; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN KINASE B BETA; TUMOR MARKER; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; PSCA PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; AGED; AKT2 GENE; APOBEC3A GENE; APOBEC3B GENE; ARTICLE; CAMTA2 GENE; CDKN2C GENE; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME 6P; CHROMOSOME 7Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC DAMAGE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MCM7 GENE; MIDDLE AGED; PANCREAS CANCER; PANCREAS TUMOR; PFN1 GENE; COPY NUMBER VARIATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; METABOLISM;

ADULT; AGED; ANTIGENS, NEOPLASM; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; GPI-LINKED PROTEINS; HMGA2 PROTEIN; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS;

EID: 84918566924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114616     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Negrini S, Gorgoulis VG, Halazonetis TD (2010) Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220-228.
3. Harada T, Okita K, Shiraishi K, Kusano N, Kondoh S, et al. (2002) Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 62: 835-839.
4. Kitoh H, Ryozawa S, Harada T, Kondoh S, Furuya T, et al. (2005) Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration. J Gastroenterol 40: 511-517.
5. Harada T, Baril P, Gangeswaran R, Kelly G, Chelala C, et al. (2007) Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation. Br J Cancer 96: 373-382.
6. Harada T, Chelala C, Bhakta V, Chaplin T, Caulee K, et al. (2008) Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene 27: 1951-1960.
7. Lehnen NC, von Massenhausen A, Kalthoff H, Zhou H, Glowka T, et al. (2013) Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma. Histopathology 63: 157-166.
8. Aumayr K, Soleiman A, Sahora K, Schindl M, Werba G, et al. (2013) HER2 Gene Amplification and Protein Expression in Pancreatic Ductal Adenocarcinomas. Appl Immunohistochem Mol Morphol.
9. Zhou J, Song SD, Li DC, Zhu DM, Zheng SY (2012) Clinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomas. Asian Pac J Cancer Prev 13: 719-724.
10. Ding X, Wang Y, Ma X, Guo H, Yan X, et al. (2014) Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition. Cell Prolif 47: 146-151.
11. Xi YN, Xin XY, Ye HM (2014) Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells. Asian Pac J Trop Med 7: 289-292.
12. Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, et al. (2013) HMGA2 is a driver of tumor metastasis. Cancer Res 73: 4289-4299.
13. Sun M, Song CX, Huang H, Frankenberger CA, Sankarasharma D, et al. (2013) HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci U S A 110: 9920-9925.
14. Baudis M, Cleary ML (2001) Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17: 1228-1229.
15. Baudis M. Progenetix oncogenomic online resource: www.progenetix.net., 2014.
16. Kulkarni MS, Daggett JL, Bender TP, Kuehl WM, Bergsagel PL, et al. (2002) Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis. Leukemia 16: 127-134.
17. Leone PE, Walker BA, Jenner MW, Chiecchio L, Dagrada G, et al. (2008) Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res 14: 6033-6041.
18. Boyd KD, Ross FM, Walker BA, Wardell CP, Tapper WJ, et al. (2011) Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival. Clin Cancer Res 17: 7776-7784.
19. Miwa W, Yasuda J, Murakami Y, Yashima K, Sugano K, et al. (1996) Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem Biophys Res Commun 225: 968-974.
20. Nitsche C, Edderkaoui M, Moore RM, Eibl G, Kasahara N, et al. (2012) The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Gastroenterology 142: 377-387 e371-375.
21. Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR (2001) AKTactivation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 61: 589-593.
22. Shi XH, Liang ZY, Ren XY, Liu TH (2009) Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo. Cancer Gene Ther 16: 227-236.
23. Chen D, Niu M, Jiao X, Zhang K, Liang J, et al. (2012) Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-kappaB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 13: 1186-1208.
24. Mussil B, Suspene R, Aynaud MM, Gauvrit A, Vartanian JP, et al. (2013) Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death. PLoS One 8: e73641.
25. Suspene R, Aynaud MM, Guetard D, Henry M, Eckhoff G, et al. (2011) Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A 108: 4858-4863.
26. Pham P, Landolph A, Mendez C, Li N, Goodman MF (2013) A biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancer. J Biol Chem 288: 29294-29304.
27. Leonard B, Hart SN, Burns MB, Carpenter MA, Temiz NA, et al. (2013) APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res.
28. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, et al. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494: 366-370.
29. Burns MB, Temiz NA, Harris RS (2013) Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45: 977-983.
30. Zhang T, Cai J, Chang J, Yu D, Wu C, et al. (2013) Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum Mol Genet 22: 1262-1269.
31. Xuan D, Li G, Cai Q, Deming-Halverson S, Shrubsole MJ, et al. (2013) APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 34: 2240-2243.
32. An P, Johnson R, Phair J, Kirk GD, Yu XF, et al. (2009) APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis 200: 1054-1058.
33. Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, et al. (2012) HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology 60: 397-404.
34. Hristov AC, Cope L, Reyes MD, Singh M, Iacobuzio-Donahue C, et al. (2009) HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 22: 43-49.
35. Watanabe S, Ueda Y, Akaboshi S, Hino Y, Sekita Y, et al. (2009) HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am J Pathol 174: 854-868.